ONXX Share Price

Open 0.00 Change Price %
High 0.00 1 Day 0.00 0.00
Low 0.00 1 Week 0.00 0.00
Close 124.70 1 Month 0.00 0.00
Volume 49364 1 Year 0.00 0.00
52 Week High 5.21
52 Week Low 0.00
ONXX Important Levels
Resistance 2 124.70
Resistance 1 124.70
Pivot 41.57
Support 1 124.70
Support 2 124.70
NASDAQ USA Most Active Stocks
SIRI 4.30 -5.49%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
QQQ 115.70 0.20%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PERF 1.90 22.58%
ASNA 7.01 20.24%
SBSA 4.60 17.95%
CEMP 7.55 15.27%
XXIA 15.55 14.76%
More..
NASDAQ USA Top Losers Stocks
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
VALV 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
RITT 0.06 -45.45%
More..

ONYX Pharmaceuticals, Inc. (NASDAQ: ONXX)

ONXX Technical Analysis 2
As on 30th Sep 2013 ONXX Share Price closed @ 124.70 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 94.66 & Sell for SHORT-TERM with Stoploss of 125.40 we also expect STOCK to react on Following IMPORTANT LEVELS.
ONXX Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
ONYX Pharmaceuticals, Inc. ( NASDAQ USA Symbol : ONXX )
Sector : Health Care Biotechnology: Biological Products (No Diagnostic Substances) And Other Stocks in Same Sector
BPAX
1.09 0.01 (0.93 %)
LT : Strong Sell
ST : Sell
LIFE
3.05 -0.05 (-1.61 %)
LT : Strong Sell
ST : Sell
NABI
1.80 0.01 (0.56 %)
LT : Buy
ST : Strong Buy
ONXX
124.70 0.00 (0.00 %)
LT : Strong Buy
ST : Sell
SGMO
3.10 0.05 (1.64 %)
LT : Strong Sell
ST : Strong Sell
ONXX Other Details
Segment EQ
Market Capital 5090100224.00
Sector Health Care Biotechnology: Biological Products (No Diagnostic Substances)
Industry
Offical website
ONXX Address
ONXX
N/A
ONXX Latest News
Interactive Technical Analysis Chart ONYX Pharmaceuticals, Inc. ( ONXX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on ONYX Pharmaceuticals, Inc.
ONXX Business Profile
Onyx Pharmaceuticals, Inc. (Onyx) is a biopharmaceutical company. The Company is developing therapies that target the molecular mechanisms that cause cancer. The Company has built two franchise platforms: one in kinase inhibition and one in proteasome inhibition. In its kinase inhibitor franchise, its product, Nexavar (sorafenib) tablets is approved for unresectable liver cancer and advanced kidney cancer. unresectable liver cancer and advanced kidney cancer. With its development and marketing partner Bayer HealthCare Pharmaceuticals Inc., or Bayer, the Company shares equally in the profits and losses of Nexavar worldwide except Japan. A kinase inhibitor, regorafenib, is an investigational agent that has already demonstrated positive Phase 3 survival data in metastatic colorectal cancer, and is being evaluated in a Phase 3 study in gastrointestinal stromal tumors (GIST).